menu

Diving into Diabetes: Investigating SGLT2 Inhibitors & Diabetic Ketoacidosis

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Diving into Diabetes: Investigating SGLT2 Inhibitors & Diabetic Ketoacidosis

close
ReachMD Healthcare Image
Restart
Resume
Read full article
Choose a format
Media formats available:
A pre-test is required to view this content.
A pre-survey is required to view this content.
Details
Presenters
Comments
  • Overview

    Dr. John Buse joins Dr. Antonios Douros, Assistant Professor in the Department of Medicine at McGill University and research investigator at Lady Davis Institute in Montreal, Quebec, to discuss his latest research focusing on SGLT2 inhibitors and diabetic ketoacidosis risk.

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    Dr. John Buse joins Dr. Antonios Douros, Assistant Professor in the Department of Medicine at McGill University and research investigator at Lady Davis Institute in Montreal, Quebec, to discuss his latest research focusing on SGLT2 inhibitors and diabetic ketoacidosis risk.

Facebook Comments

Programs 9/18/21